BridgeMD
New treatment option for Vertebral Fracture
Official title Examination of Vertebroplasty in Addition to Regular Treatment of Patients With Multiple Myeloma.
ClinicalTrials.gov ID: NCT04533217
What this study is testing
- What it's testing
- Patients with newly diagnosed or known multiple myeloma with newly diagnosed vertebral lesion(s) will be invited to participate in a cross-sectoral randomized controlled trial. The trial will compare two groups of patients which either receive regular medical treatment of their vertebral lesion(s) or vertebroplasty in addition to regular medical treatment.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- known multiple myeloma
- verified lesion(s) between Th6-L5
- 4 or less fractures
- relevant pain in 3 months or less
- vertebroplasty can be performed in one procedure
You likely can't join if
- presence of neurologic deficit
- psychological or psychiatric disorder hat is expected to interfere with compliance
See the full eligibility criteria
- known multiple myeloma
- verified lesion(s) between Th6-L5
- 4 or less fractures
- relevant pain in 3 months or less
- vertebroplasty can be performed in one procedure
- VAS 5 or more
- presence of neurologic deficit
- psychological or psychiatric disorder hat is expected to interfere with compliance
The study team makes the final eligibility decision.
Where it's taking place
- Middelfart, Region Syddanmark, Denmark
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Middelfart, Region Syddanmark, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.